Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SOLIGENIX, INC. Director's Dealing 2023

Dec 15, 2023

35119_dirs_2023-12-15_7e6743be-83f3-4b4f-928b-e993363e5bcc.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SOLIGENIX, INC. (SNGX)
CIK: 0000812796
Period of Report: 2023-12-15

Reporting Person: ZELDIS JEROME B (N/A)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2023-12-15 Stock Option (Right to Buy) $0.59 A 38136 Acquired 2033-12-14 Common Stock (38136) Direct

Footnotes

F1: The stock option vests ratably on each of March 15, 2024, June 15, 2024, September 15, 2024 and December 15, 2024.